Panelists discuss how current multiple sclerosis (MS) therapies show limited effectiveness against progression, but emerging ...

A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential ...

A trial using PET scans to test the anti-inflammatory drug PIPE-791 finished enrolling healthy volunteers and patients with ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

Anti-CD20 therapies, a type of MS treatment, changes levels and profiles of several immune cells in people with MS, a study ...

Panelists discuss how chronic neuroinflammation involves distinct mechanisms from acute relapses—including microglial ...

Illinois engineers fused ultrafast imaging with smart algorithms to peek at living brain chemistry, turning routine MRIs into ...

NMC’s new regulations allow MSc-PhD holders to teach Pharmacology and Microbiology, treating them on par with MD/MS. Key ...

David said patients "deserve the right to decide what happens to their tissue, so whether it would be used for research, for ...

The new law enters North Carolina into the interstate PA licensure compact and eliminates supervisory requirements for experienced PAs who practice in team-based settings.

ORLANDO, FLORIDA / ACCESS Newswire / July 3, 2025 / RedChip Companies will air interviews with Fathom Holdings, Inc.

Stuve, O. et al. Clinical stabilization and effective B-lymphocyte depletion in the cerebrospinal fluid and peripheral blood of a patient with fulminant relapsing-remitting multiple sclerosis.